Neoplastic Meningitis Clinical Trials
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer
Conditions: Leptomeningeal Metastasis; Lung Cancer Intervention: Drug: Nimotuzumab Sponsor: Hui Bu Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2021 Category: Research Source Type: clinical trials